ESMO Highlights

flipper_slider

Editor's Choice

Dr Antonio Llombart-Cussac discusses data from the CASCADE study. FILMED AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) ANNUAL MEETING, OCTOBER 2016.

ESMO Highlights Videos

Coverage of the Bayer supported satellite symposium "Radium-223 from bench to bedside and future directions for targeted alpha therapy " at TAT 2017. The video has been published on the touchONCOLOGY website with permission from Bayer.
Mario Mandala, Vanna Cahiarrion-Sileni and Jean-Jacques Grob discuss the short- and long-term benefit-risk balance issues for different treatment options with patients with metastatic BRAF-positive melanoma. Support: The filming of this video was supported by Novartis.
Mario Mandala, Vanna Cahiarrion-Sileni and Jean-Jacques Grob discuss "How does the recently presented data on BRAK/MEK inhibitors and immunotherapy impact your choice of treatment for patients with BRAF-positive melanoma" at ESMO 2017. Support: The filming of this video was supported by Novartis.
Joe O'Sullivan discusses the role of radium-223 in the mestastatic prostate cancer treatment paradigm. Support: The filming of this video was supported by Bayer. Disclosures: Joe O'Sullivan has participated in Advisory Boards with Bayer, Sanofi and Janssen.
Dr Florian Scotte discusses the role of rolapitant on chemotherapy-induced nausea and vomiting. Interview in French. Speaker disclosures: Consultant, speaker or advisory board with: Roche, Vifor, MSD, TEVA, Norgine, Prostrakan, Leo pharma, Janssen, Hospira, Boehringer, Sanofi, AMGEN, Pierre...
Dr Massimo Di Maio discusses the role of rolapitant on chemotherapy-induced nausea and vomiting. Interview in Italian. Speaker disclosures: Received honoraria or acted as consultant for Bayer, Eli Lilly, AstraZeneca, Janssen, Bristol Myers Squibb, Merck Sharp...
Dr Pere Gascon discusses the role of rolapitant on chemotherapy-induced nausea and vomiting. Interview in Spanish. Filmed at the ESMO annual meeting, 2017
Dr Karin Jordan discusses the role of rolapitant on chemotherapy-induced nausea and vomiting. Interview in German. Speaker disclosures: Karin Jordan is a consultant for Tesaro. Filmed at the ESMO annual meeting, 2017
Axel Merseburger, Shaji Kumar, Sharlene Gill, Ahmad Awada, Paolo Ascierto and Maurice Perol discuss their experiences with the European Oncology...
Sharlene Gill discusses the latest developments in pancreatic cancer and the current treatment guidelines. You can read Dr Gill's latest article on pancreatic cancer here
Paolo Asceirto, from our European editorial board, discusses the challenges and recent advances in the treatment of advanced melanoma.
Iain McNeish discusses the role of PARP inhibitors, including rucaparib in the treatment of ovarian cancer.
Ahmad Awada, from our editorial board, discusses the current and future developments in immunotherapy.
Marwan Fakih discusses the implications of primary tumour location on biological therapy in metastatic colorectal cancer.
Frédérique Penault Llorca discusses the latest research into biomarkers and the predictability of immunotherapy response.